Koss-Olinger Consulting, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1861163
GAINESVILLE, FL
Position in VRTX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$288,464
-$10,300 QoQ
Shares Held
646
-2.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
All Filings in VRTX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $288,464 | 646 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $298,764 | 659 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $374,799 | 957 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $426,056 | 957 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $483,850 | 998 | Shares | Sole | 2025-05-12 | |
| 2024-09-30 | $416,711 | 896 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $403,567 | 861 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $1,428,997 | 3,512 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,357,924 | 3,905 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $1,398,138 | 3,973 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $1,251,773 | 3,973 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,132,595 | 3,922 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,984,217 | 6,853 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,973,093 | 7,002 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $2,178,577 | 8,348 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,783,152 | 8,120 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $682,933 | 3,765 | Shares | Sole | 2021-11-09 | |
| No filing history on record for this holder in this stock. | ||||||